Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

Tinhofer, I; Rubenzer, G; Holler, C; Hofstaetter, E; Stoecher, M; Egle, A; Steurer, M; Greil, R; Blood. 2006; 108(9):2950-2956

[Palliative therapy in glioblastoma multiforme: a multimodal concept].

Faber, V; Thödtmann, R; Marosi, C; Wien Med Wochenschr. 2006; 156(9-10): 255-259.

Adjuvant treatment with trastuzumab in clinical practice outside clinical studies

Senn, HJ; Thurlimann, B; von Minckwitz, G; Herrmann, R; Jakesz, R; Gnant, M; Greil, R BREAST CARE. 2006; 1(2): 96-101.

Clinical practice aromatase inhibitors: Upfront, switch or extended?

Greil, R; Jonat, W; Maass, N; Kaufmann, M; Ortmann, O; Possinger, K; Steger, G BREAST CARE. 2006; 1(1): 37-43.

Diffuse large B-cell lymphoma as a second, clonally unrelated lymphoproliferative disease in a patient with IgM monoclonal gammopathy of undetermined significance (MGUS) and concomitant polycythemia vera rubra.

Mian, M; Psenak, O; Greil, R; Fiegl, M; Tzankov, A; LEUKEMIA LYMPHOMA. 2006; 47(5): 940-943.

The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trial.

Tinhofer, I; Steurer, M; Leitinger, G; Rumpold, H; Egle, A; Erdel, M; Greil, R; Haematologica. 2006; 91(9): 1291-1293.

Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.

Fiegl, M; Falkner, A; Hopfinger, G; Brugger, S; Zabernigg, A; Bauer, F; Haslbauer, F; Demirtas, D; Grossschmidt, P; Tatzreiter, G; Gastl, G; Greil, R; CANCER. 2006; 107(10): 2408-2416.

Purine antagonists for chronic lymphocytic leukaemia.

Steurer, M; Pall, G; Richards, S; Schwarzer, G; Bohlius, J; Greil, R; Cochrane Database Syst Rev. 2006; (3): CD004270

Targeted therapies in non-small cell lung cancer: proven concepts and unfulfilled promises.

Auberger, J; Loeffler-Ragg, J; Wurzer, W; Hilbe, W; Curr Cancer Drug Targets. 2006; 6(4): 271-294.

Therapy of antibody-mediated factor VIII deficiency by immunosuppressive therapy containing cyclophosphamide, dexamethasone and rituximab: A case report

Thoedtmann, R; Rosenlechner, S; Unger, J; Patsch, W; Greil, R HAEMATOL-HEMATOL J. 2007; 92: 546-546.